VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
VYCFX
Price
$26.26
Change
+$0.15 (+0.57%)
Updated
Jul 3 closing price
Net Assets
1.17B
Interact to see
Advertisement

VVIAX vs VYCFX

Header iconVVIAX vs VYCFX Comparison
Open Charts VVIAX vs VYCFXBanner chart's image
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
Voya Corporate Leaders 100 R
Price$26.26
Change+$0.15 (+0.57%)
VolumeN/A
Net Assets1.17B
VVIAX vs VYCFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VVIAX vs. VYCFX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VVIAX is a Buy and VYCFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. VYCFX (1.17B). VVIAX pays higher dividends than VYCFX: VVIAX (2.18) vs VYCFX (1.24). VVIAX was incepted earlier than VYCFX: VVIAX (25 years) vs VYCFX (13 years). VYCFX (1.11) is less costly to investors than VVIAX (0.05). VYCFX is a more actively managed with annual turnover of: 24.00 vs. VVIAX (9.00). VYCFX has a lower initial minimum investment than VVIAX: VYCFX (0) vs VVIAX (3000). VYCFX annual gain was more profitable for investors over the last year : 13.63 vs. VVIAX (12.03). VVIAX return over 5 years is better than : 80.13 vs. VYCFX (42.38).
VVIAXVYCFXVVIAX / VYCFX
Total Expense Ratio0.051.115%
Annual Report Gross Expense Ratio0.051.115%
Fund Existence25 years13 years-
Gain YTD6.19810.56859%
Front LoadN/AN/A-
Min. Initial Investment30000-
Min. Initial Investment IRAN/AN/A-
Net Assets189B1.17B16,209%
Annual Yield % from dividends2.181.24176%
Returns for 1 year12.0313.6388%
Returns for 3 years35.1742.9382%
Returns for 5 years80.1342.38189%
Returns for 10 years115.6763.93181%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.